Dr. Adeyeye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2139 Georgia Ave Nw
Howard University Hospital Family Health Center
Washington, DC 20001Phone+1 202-865-3250Fax+1 202-865-7202
Education & Training
Howard UniversityResidency, Family Medicine, 2007 - 2010
Obafemi Awolowo University, Ile-IfeClass of 2000
Certifications & Licensure
NM State Medical License 2021 - 2027
MD State Medical License 2009 - 2026
TX State Medical License 2023 - 2026
WA State Medical License 2019 - 2026
ID State Medical License 2019 - 2025
MT State Medical License 2019 - 2025
OR State Medical License 2020 - 2025- American Board of Family Medicine Family Medicine
- Join now to see all
Publications & Presentations
PubMed
- 120 citationsSafety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trialRaphael J. Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y. Liu
Plos Medicine. 2018-11-08 - 26 citationsCabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077.Raphael J. Landovitz, Sahar Z Zangeneh, Gordon Chau, Beatriz Grinsztejn, Joseph J. Eron
Clinical Infectious Diseases. 2020-01-02 - 87 citationsTail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.Raphael J. Landovitz, Sue Li, Joseph J. Eron, Beatriz Grinsztejn, Halima Dawood
The Lancet. HIV. 2020-07-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
